Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment

Journal of Infection(2022)

引用 4|浏览7
暂无评分
摘要
•The cycle threshold (Ct) value of RT-PCR was not significantly reduced by remdesivir.•Infectious virus was not detected after the third dose of remdesivir despite dexamethasone treatment.•SARS-CoV-2 shedding significantly decreased after remdesivir treatment, regardless of the Ct value.•Rapid antigen test is a viable adjunctive tool that guides the decision to terminate the isolation.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要